NeraCare
PrivateLast Round
Series A
Mar 11, 2020
Total Funding Raised
$9.04M
Company Overview
NeraCare operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Series A round in March 2020.
NeraCare is a biotechnology company that develops and commercializes molecular diagnostic tests for personalized survival prediction in melanoma patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeraCare Comparables
Compare NeraCare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AMLo Biosciences | 84% | |
| SkylineDx | 84% | |
| Castle Biosciences, Inc. | 77% |
For institutional investors. Book with your work email.
NeraCare Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeraCare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BayBG Bayerische Beteiligungsgesellschaft | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 11, 2020
$9M round led by mig-fonds-10-14-and-16
For institutional investors. Book with your work email.
NeraCare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeraCare's valuation, stock price, and market status.
Is NeraCare a public or private company?
NeraCare is a private company.
What is the current stock price of NeraCare?
NeraCare is a private company, so its shares have no public market price. Caplight tracks NeraCare's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeraCare worth (valuation)?
Valuation information for NeraCare is not publicly available.
Can I buy NeraCare stock?
NeraCare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeraCare's last funding round?
NeraCare's most recent funding round was Series A on March 11, 2020.
Who are the main investors in NeraCare?
Key investors in NeraCare include BayBG Bayerische Beteiligungsgesellschaft.
Will NeraCare IPO soon?
No public IPO plans have been announced for NeraCare.
How can I track NeraCare secondary market activity?
Caplight tracks bids, offers, and trades in NeraCare's shares on secondary markets.